Infectious Diseases journals by time to acceptance (2025)
50 journals with 2025 figures · median days from submission to acceptance, measured from PubMed dates · data as of Sep 15, 2026
Sorted by median days from submission to acceptance in 2025. Faster is not better — this is a planning aid, not a ranking of quality. Click a column to re-sort.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Viruses | 38 (28–52) | 1,587 | 3 | ≈$3,178 | Open access (DOAJ) | 0.45 |
| Vaccines | 39 (31–49) | 1,239 | 3 | ≈$3,300 | Open access (DOAJ) | 0.37 |
| Tropical Medicine and Infectious Disease | 46 (34–63) | 335 | 4 | ≈$3,300 | Open access (DOAJ) | 0.56 |
| The Lancet Infectious Diseases | 47 (5–82) | 224 | 60 | ≈$7,280 | Hybrid | 0.0 |
| IJTLD OPEN | 55 (38–84) | 106 | 113 | ≈$3,577 | Open access (DOAJ) | — |
| Medical Mycology Case Reports | 55 (33–84) | 65 | 3 | $650 | Open access (DOAJ) | 0.0 |
| IJID Regions | 57 (36–90) | 224 | 3 | $1,380 | Open access (DOAJ) | 0.0 |
| Infectious Diseases and Therapy | 58 (39–84) | 174 | 21 | $7,675 | Open access (DOAJ) | 0.0 |
| International Journal of Infectious Diseases | 59 (40–83) | 481 | 3 | $3,500 | Open access (DOAJ) | 0.38 |
| Infectious Disease Reports | 60 (49–75) | 149 | 5 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| Infection and Chemotherapy | 64 (40–86) | 60 | — | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Infezioni in Medicina | 66 (49–87) | 50 | 40 | — | — | 0.0 |
| Journal of Epidemiology and Global Health | 67 (44–111) | 139 | 18 | $2,790 | Open access (DOAJ) | 2.11 |
| China CDC Weekly | 77 (41–111) | 260 | — | — | Open access | 0.0 |
| Infectious Diseases and Clinical Microbiology | 77 (55–130) | 71 | 103 | — | — | — |
| The Lancet HIV | 78 (8–135) | 120 | 75 | ≈$7,280 | — | 0.0 |
| International Journal of Mycobacteriology | 79 (58–99) | 62 | 34 | $200 | Open access (DOAJ) | 0.0 |
| Clinical Infectious Diseases | 83 (65–111) | 179 | — | ≈$4,763 | Hybrid | 0.58 |
| AIDS Research and Therapy | 83 (63–136) | 139 | 28 | $3,090 | Open access (DOAJ) | 2.04 |
| Reviews in Medical Virology | 88 (45–148) | 71 | — | ≈$4,880 | — | 0.0 |
| Anaerobe | 89 (67–121) | 75 | 4 | ≈$3,350 | — | 0.0 |
| Osong Public Health and Research Perspectives | 90 (68–106) | 50 | 39 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| AIDS | 93 (59–134) | 322 | 24 | — | Hybrid | 0.0 |
| Journal of Hospital Infection | 94 (66–128) | 274 | 17 | ≈$4,000 | Hybrid | 0.0 |
| Journal of Infection | 99 (71–134) | 185 | 5 | $4,030 | Open access (DOAJ) | 0.0 |
| HIV Medicine | 99 (71–136) | 159 | 15 | ≈$4,150 | — | 0.0 |
| American Journal of Infection Control | 101 (75–126) | 225 | 6 | ≈$3,360 | — | 0.0 |
| Open Forum Infectious Diseases | 102 (70–139) | 708 | 5 | $3,859 | Open access (DOAJ) | 0.28 |
| Clinical Microbiology and Infection | 103 (66–138) | 280 | 7 | ≈$3,780 | Hybrid | 0.0 |
| The Journal of Infectious Diseases | 109 (78–145) | 495 | — | ≈$4,763 | Hybrid | 0.37 |
| International Journal of Medical Microbiology | 110 (87–157) | 51 | 2 | $3,480 | Open access (DOAJ) | — |
| EClinicalMedicine | 112 (84–140) | 627 | 20 | $6,810 | Open access (DOAJ) | 0.35 |
| Tuberculosis | 112 (84–140) | 67 | 1 | ≈$2,690 | — | 0.0 |
| Biosafety and Health | 113 (89–134) | 52 | 2 | $2,250 | Open access (DOAJ) | — |
| The Indian Journal of Medical Research | 117 (79–170) | 264 | — | — | Open access | 1.25 |
| Journal of Medical Virology | 125 (89–167) | 563 | — | ≈$4,730 | Hybrid | 0.92 |
| Current HIV Research | 126 (104–152) | 61 | — | — | — | 0.0 |
| Journal of Infection and Public Health | 128 (87–179) | 343 | 3 | $2,310 | Open access (DOAJ) | 2.19 |
| Journal of the Pediatric Infectious Diseases Society | 135 (85–172) | 102 | — | ≈$4,752 | — | 0.0 |
| Infectious Disorders - Drug Targets | 140 (113–183) | 63 | — | — | — | 2.75 |
| BMC Infectious Diseases | 142 (92–261) | 2,012 | 21 | $3,190 | Open access (DOAJ) | 0.61 |
| npj Vaccines | 142 (109–181) | 287 | 21 | $4,090 | Open access (DOAJ) | 0.0 |
| JAIDS Journal of Acquired Immune Deficiency Syndromes | 161 (118–208) | 159 | — | — | — | 0.86 |
| Therapeutic Advances in Infectious Disease | 164 (120–219) | 94 | 35 | $2,800 | Open access (DOAJ) | 0.0 |
| Infection Prevention in Practice | 167 (122–227) | 51 | 14 | $1,500 | Open access (DOAJ) | 0.0 |
| The Lancet Microbe | 168 (14–271) | 157 | 100 | $8,570 | Open access (DOAJ) | 0.0 |
| Journal of Microbiology Immunology and Infection | 176 (124–272) | 116 | 4 | $2,000 | Open access (DOAJ) | 0.0 |
| Canadian Journal of Infectious Diseases and Medical Microbiology | 181 (140–260) | 84 | 22 | $2,380 | Open access (DOAJ) | 0.0 |
| Case Reports in Infectious Diseases | 206 (144–284) | 123 | 20 | $870 | Open access (DOAJ) | 0.0 |
| Journal of the International AIDS Society | 207 (167–238) | 154 | — | $2,860 | Open access (DOAJ) | 0.0 |
Journals are listed where at least 25% of their articles' topics fall in Infectious Diseases (OpenAlex).
Latest available year: 2024
4 journals without enough usable 2025 data. Their 2024 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| World Journal of Virology | 85 (67–128) | 55 | — | — | Open access | — |
| Food and Environmental Virology | 89 (60–131) | 50 | 32 | ≈$2,990 | — | 0.0 |
| npj Viruses | 89 (69–111) | 70 | 42 | $2,790 | Open access (DOAJ) | — |
| Indian Journal of Tuberculosis | 98 (53–145) | 106 | 1 | — | — | 0.0 |
Latest available year: 2023
2 journals without enough usable 2025 data. Their 2023 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| HIV/AIDS - Research and Palliative Care | 79 (60–110) | 63 | 10 | $3,565 | Open access (DOAJ) | 6.71 |
| Global Health & Medicine | 101 (71–152) | 70 | — | — | — | 0.0 |
Latest available year: 2022
2 journals without enough usable 2025 data. Their 2022 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Interdisciplinary Perspectives on Infectious Diseases | 83 (56–143) | 57 | 18 | $950 | Open access (DOAJ) | — |
| GERMS | 146 (112–188) | 55 | 41 | — | — | 0.0 |
Latest available year: 2021
2 journals without enough usable 2025 data. Their 2021 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Journal of Clinical Microbiology | 87 (57–123) | 59 | 64 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Public Health Action | 99 (65–121) | 54 | — | ≈$2,654 | Open access (DOAJ) | 0.0 |
Latest available year: 2020
2 journals without enough usable 2025 data. Their 2020 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Southern African Journal of HIV Medicine | 41 (25–59) | 56 | 70 | ≈$838 | Open access (DOAJ) | — |
| Journal of Global Infectious Diseases | 73 (20–147) | 63 | 142 | $650 | Open access (DOAJ) | 0.0 |
Have a deadline?
Pick up to five journals and see whether a submission sequence can realistically reach acceptance before your defence, visa or job-market date. Free.
Open the submission plannerFrequently asked questions
Which Infectious Diseases journals accepted papers fastest in 2025?
Among 50 Infectious Diseases journals with enough dated articles in 2025, the shortest median time from submission to acceptance was 38 days (Viruses). The middle journal's median was 99 days. Speed is not a measure of quality; check scope, indexing and fees too.
How are these times measured?
From the submission and acceptance dates publishers deposit in PubMed, for accepted articles only. Each journal needs at least 50 dated articles in the year shown, and a table headed with a year contains only that year's figures.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.